Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Critical Outcome Technologies has announced that all three of the collaboration research and development (R&D) projects announced in the fall of 2012 are on time and progressing.
Subscribe to our email newsletter
The collaborations include a drug discovery project with Western University; a co-development project with Delmar Chemicals; and a drug discovery project with a major global pharmaceutical company.
Critical Outcome Technologies president and CEO Wayne Danter said that success with these projects will provide ongoing independent third party validation of Chemsas as a powerful artificial intelligence drug discovery engine across multiple targets and as a commercial asset.
"Each of these co-development discovery projects has significant revenue generating potential, and based upon recently completing a few pilot projects, we are seeking to add additional collaborations during 2013," Danter added.